Ryan Barbara
19 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-04 | INKT | MiNK Therapeutics, Inc. | Sale | 1,000 | $12.80 | $12,799.50 | filing |
| 2026-06-04 | INKT | MiNK Therapeutics, Inc. | Sale | 500 | $12.68 | $6,341.75 | filing |
| 2026-06-01 | INKT | MiNK Therapeutics, Inc. | Award | 1,434 | $12.38 | $17,752.92 | filing |
| 2026-05-13 | INDV | Indivior Pharmaceuticals, Inc. | Award | 6,518 | $0.00 | $0.00 | filing |
| 2026-03-13 | INDV | Indivior Pharmaceuticals, Inc. | Buy | 8 | $31.09 | $248.68 | filing |
| 2026-03-10 | INKT | MiNK Therapeutics, Inc. | Sale | 500 | $15.57 | $7,782.60 | filing |
| 2026-03-10 | INKT | MiNK Therapeutics, Inc. | Sale | 500 | $15.30 | $7,650.00 | filing |
| 2026-03-10 | INKT | MiNK Therapeutics, Inc. | Sale | 300 | $15.28 | $4,584.66 | filing |
| 2026-03-09 | INKT | MiNK Therapeutics, Inc. | Sale | 200 | $10.17 | $2,034.50 | filing |
| 2026-03-09 | INDV | Indivior Pharmaceuticals, Inc. | Buy | 31 | $32.56 | $1,009.36 | filing |
| 2026-03-02 | INKT | MiNK Therapeutics, Inc. | Award | 1,629 | $10.90 | $17,756.10 | filing |
| 2026-03-02 | INKT | MiNK Therapeutics, Inc. | Sale | 100 | $10.83 | $1,082.58 | filing |
| 2026-03-02 | INKT | MiNK Therapeutics, Inc. | Sale | 100 | $10.83 | $1,082.58 | filing |
| 2026-02-27 | INKT | MiNK Therapeutics, Inc. | Sale | 400 | $10.86 | $4,343.32 | filing |
| 2026-02-27 | INKT | MiNK Therapeutics, Inc. | Sale | 400 | $10.86 | $4,343.32 | filing |
| 2026-01-26 | INDV | Indivior Pharmaceuticals, Inc. | Award | 3,722 | $0.00 | $0.00 | filing |
| 2026-01-05 | INDV | Indivior Pharmaceuticals, Inc. | Buy | 775 | $35.39 | $27,429.27 | filing |
| 2025-12-01 | INKT | MiNK Therapeutics, Inc. | Award | 1,601 | $11.09 | $17,755.09 | filing |
| 2025-09-02 | INKT | MiNK Therapeutics, Inc. | Award | 1,281 | $13.86 | $17,754.66 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.